Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
04.03.25
/
50%
€133.42
Target price
04.03.26
€146.25
Performance (%)
-26.22%
Price
27.02.26
€98.44
This prediction will end soon
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.22%. This prediction currently runs until 04.03.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 3.393% | 3.393% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $138.00 to $154.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€92.26
23.01.26
23.01.26
€119.18
23.01.27
23.01.27
6.70%
27.02.26
27.02.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€106.22
15.01.26
15.01.26
€130.60
15.01.27
15.01.27
-7.85%
27.02.26
27.02.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.08
01.10.25
01.10.25
€133.73
01.10.26
01.10.26
-14.46%
27.02.26
27.02.26